GlassScriptPhysician profile
Janice T Knowlton
NPI 1912116096
$12,508.72
in general payments reported to CMS, 2019-2025
41 companies · $3,450 in 2025
The $3,450 reported for 2025 was more than what 96% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,269 · 2022: $2,249 · 2023: $2,199 · 2024: $2,341 · 2025: $3,450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,990.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,990.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $2,113.39 | 2021-2025 | Repatha, Otezla, Evenity |
| Glaxosmithkline, LLC. | $1,196.16 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $1,191.02 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $984.68 | 2021-2025 | |
| Novo Nordisk INC | $829.03 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Otsuka America Pharmaceutical, INC. | $617.45 | 2021-2025 | Rexulti |
| Novartis Pharmaceuticals Corporation | $530.49 | 2021-2025 | |
| Daiichi Sankyo INC. | $502.09 | 2021-2025 | Injectafer |
| Pfizer INC. | $468.52 | 2022-2025 | |
| Radius Health, INC. | $460.02 | 2021-2025 | Tymlos |
| Bayer Healthcare Pharmaceuticals INC. | $347.84 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $327.61 | 2021-2025 | Verquvo, Belsomra, Steglatro |
| Lilly USA, LLC | $296.65 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $285.94 | 2021-2025 | Jardiance, Tradjenta |
| Janssen Pharmaceuticals, INC | $272.09 | 2021-2024 | Xarelto |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $236.47 | 2022-2025 | Korlym |
| Heartflow, INC. | $190.76 | 2025 | |
| Phathom Pharmaceuticals, INC. | $167.20 | 2024-2025 | Voquezna |
| Electromed, INC. | $132.15 | 2021-2025 | Smartvest |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.42 | 2021-2025 | Xifaxan |
| Shield Therapeutics INC | $124.07 | 2023-2025 | Accrufer |
| Lundbeck LLC | $118.72 | 2021-2025 | Rexulti |
| Baxter Healthcare | $111.63 | 2023-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System |
| Philips North America LLC | $109.64 | 2021-2023 | |
| Verona Pharma, INC. | $99.44 | 2025 | Ohtuvayre |
| Abbott Laboratories | $94.80 | 2023 | Cardiomems |
| Dexcom, INC. | $77.82 | 2021-2023 | Dexcom G6 Transmitter |
| Nevro Corp. | $73.04 | 2023-2024 | Senza |
| Horizon Therapeutics Plc | $68.42 | 2022-2023 | Krystexxa |
| Esperion Therapeutics, INC. | $55.39 | 2021 | |
| Exact Sciences Corporation | $39.69 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $39.49 | 2022 | |
| Amarin Pharma, INC. | $36.83 | 2021 | |
| Biosense Webster, INC. | $33.15 | 2023 | Qdot Micro Catheter |
| Abiomed | $32.35 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $25.24 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $23.11 | 2025 | Uzedy |
| Advanced Respiratory, INC | $19.54 | 2021 | |
| Eisai INC. | $18.28 | 2025 | |
| Boston Scientific Corporation | $17.44 | 2025 | General - Pain Management |
| Medtronic, INC. | $16.65 | 2023 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janice Knowlton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.